Approval · Notice of Compliance 13136 · 2012
ROCURONIUM BROMIDE INJECTION: Notice of Compliance 13136
Issued March 23, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13136
- Date
- March 23, 2012
- Company
- Omega Laboratories LimitedMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Non-depolarizing Skeletal Neuromuscular Blocking Agent
- Canadian reference product
- ZEMURON (Schering-Plough Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ROCURONIUM BROMIDE INJECTION | 02382415 | Cancelled Post Market |
Medicinal ingredients
- ROCURONIUM BROMIDE 10 MG per ML